By Connor Hart
Shares of Tenon Medical rose after the company received notice of two approvals from the European patent office.
The stock gained 40%, to $1.75, in after-hours trading Monday. Shares ended the regular session 3.8% lower, at $1.25, and have lost almost 90% of their value in the past year.
The Los Gatos, Calif., medical-device company said after the bell that two additional patents related to its Catamaran Sacroiliac Joint Fixation Device have been approved for grant of a European patent within the European Community.
"Receiving notification of approval for two additional patents by the European patent office reinforces Tenon's increasingly robust patent position worldwide as well as our commitment to continued innovation," Chief Technology Officer Richard Ginn said.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
March 10, 2025 17:28 ET (21:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。